Statements (48)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:pharmaceuticals
|
gptkbp:administered_by |
oral capsule
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:contains |
fluoxetine
|
gptkbp:contraindication |
concurrent use of monoamine oxidase inhibitors
concurrent use of pimozide concurrent use of thioridazine allergy to fluoxetine |
gptkbp:dosage_form |
weekly dosage
|
https://www.w3.org/2000/01/rdf-schema#label |
Prozac Weekly
|
gptkbp:ingredients |
gptkb:bulimia_nervosa
obsessive-compulsive disorder premenstrual dysphoric disorder panic disorder |
gptkbp:interacts_with |
NSAIDs
MAO inhibitors blood thinners other antidepressants |
gptkbp:is_administered_once |
weekly
|
gptkbp:is_available_in |
generic form
|
gptkbp:is_available_in_strengths |
10 mg
20 mg 30 mg 60 mg 90 mg |
gptkbp:is_part_of |
mental health treatment
selective serotonin reuptake inhibitors (SSRIs) |
gptkbp:is_part_of_treatment_plan_for |
major depressive disorder
|
gptkbp:is_used_for |
gptkb:depression
anxiety disorders |
gptkbp:manufacturer |
gptkb:Eli_Lilly_and_Company
|
gptkbp:side_effect |
dizziness
fatigue nausea insomnia dry mouth sexual dysfunction |
gptkbp:suitable_for |
patients with liver disease
pregnant women without consultation patients with a history of suicidal thoughts patients with a history of seizures patients taking certain medications breastfeeding women without consultation children under 18 without supervision patients with bipolar disorder without mood stabilizers |
gptkbp:was_approved_in |
gptkb:1987
|
gptkbp:bfsParent |
gptkb:Prozac
|
gptkbp:bfsLayer |
7
|